Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Dan Janney
AddedMar 31, 2024
UpdatedMay 31, 2026
Dan Janney

Dan Janney

Board Member, Krystal Biotech

Crunchbase

Dan Janney's Career

Krystal Biotech
Krystal Biotech

Pittsburgh, PA, US

Board Member· Board
Alba Therapeutics
Alba Therapeutics

Baltimore, MD, US

Board Member· Board
Arete Therapeutics
Arete Therapeutics

Hayward, CA, US

Board Member· Board
Novome Biotechnologies
Novome Biotechnologies

South San Francisco, CA, US

Board Member· Board
CuraSen Therapeutics
CuraSen Therapeutics

San Carlos, CA, US

Board Member· Board
Evolve Biosystems
Evolve Biosystems

Davis, CA, US

Board Member· Board
Prolacta Bioscience
Prolacta Bioscience

City of Industry, CA, US

Board Member· Board
Lassen Therapeutics
Lassen Therapeutics

San Diego, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Dan Janney's Career

Krystal Biotech
Krystal Biotech
Public$546M2102017Pittsburgh, PA, US
Board Member· Board

Leadership at Krystal Biotech

Krish KrishnanKrish KrishnanCEO
Rand SutherlandRand SutherlandBoard Member
Julian GangolliJulian GangolliBoard Member
Chris MasonChris MasonBoard Member
Suma KrishnanSuma KrishnanBoard Member
Alba Therapeutics
Alba Therapeutics
Series A$30M72004Baltimore, MD, US
Board Member· Board

Leadership at Alba Therapeutics

Matt ZugaMatt ZugaBoard Member
Wendy PerrowWendy PerrowBoard Member
Bruce PeacockBruce PeacockBoard Member

Similar to Alba Therapeutics

Aliva BiopharmaceuticalsAliva BiopharmaceuticalsPasadena, CA, USBiotechnologyest. 2009Aliva BiopharmaceuticalsPasadena, CA, US · est. 2009

Aliva Biopharmaceuticals: A leading innovator in the biotechnology industry.

Series A · $12.9M5
Anthera PharmaceuticalsAnthera PharmaceuticalsHayward, CA, USPharmaceuticalsest. 2004Anthera PharmaceuticalsHayward, CA, US · est. 2004

Anthera Pharmaceuticals: A US biopharma firm specializing in inflammation and autoimmune disease treatments.

Public · $101.5M21
Aristea TherapeuticsAristea TherapeuticsSan Diego, CA, USDrugsest. 2018Aristea TherapeuticsSan Diego, CA, US · est. 2018

Aristea Therapeutics: Developing novel drugs for autoimmune and inflammatory diseases.

Series B · $117.6M75
Arete Therapeutics
Arete Therapeutics
Public$51.7M302003Hayward, CA, US
Board Member· Board

Leadership at Arete Therapeutics

James H. SabryJames H. SabryCEO
John HamerJohn HamerFounder
Novome Biotechnologies
Novome Biotechnologies
Series B$83.1M302016South San Francisco, CA, US
Board Member· Board

Leadership at Novome Biotechnologies

Will DeLoacheWill DeLoacheCo-Founder
Blake WiseBlake WiseBoard Member
Andy SchwabAndy SchwabBoard Member
Weston WhitakerWeston WhitakerCo-Founder
Kiersten SteadKiersten SteadBoard Member
Zachary RussZachary RussCo-Founder

Similar to Novome Biotechnologies

Noveome BiotherapeuticsNoveome BiotherapeuticsPittsburgh, PA, USBiotherapeuticsest. 2000Noveome BiotherapeuticsPittsburgh, PA, US · est. 2000

Noveome Biotherapeutics: Clinical-stage company pioneering regenerative therapies for damaged tissues.

Series E · $43.3M24
Petri BioPetri BioLos Angeles, CA, USTherapeuticsest. 2019Petri BioLos Angeles, CA, US · est. 2019

Petri Bio: A biotech firm innovating gut microbe-based therapeutics.

Seed · $255k3
CuraSen Therapeutics
CuraSen Therapeutics
Series A$95.9M382016San Carlos, CA, US
Board Member· Board

Leadership at CuraSen Therapeutics

Mehrdad ShamlooMehrdad ShamlooCo-Founder
Kathleen Sereda GlaubKathleen Sereda GlaubBoard Member
Anthony FordAnthony FordCo-Founder
Robert BoothRobert BoothCo-Founder
Patrick EnrightPatrick EnrightBoard Member
Evolve Biosystems
Evolve Biosystems

Davis, CA, US

Board Member· Board
Prolacta Bioscience
Prolacta Bioscience

City of Industry, CA, US

Board Member· Board
Lassen Therapeutics
Lassen Therapeutics
Series B$116M232019San Diego, CA, US
Board Member· Board

Leadership at Lassen Therapeutics

Mark BarrettMark BarrettCo-Founder
David KingDavid KingCo-Founder
Jamie TopperJamie TopperBoard Member
Maria FardisMaria FardisBoard Member
Lisa OlsonLisa OlsonBoard Member

Dan Janney's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoSean JohSean JohBoard Member · KakaoSong Ji-Ho 'DeanSong Ji-Ho 'DeanBoard Member · KakaoYun SeokYun SeokBoard Member · Kakao

People Similar to Dan Janney

Robert AlexanderRobert AlexanderBoard Member · Sonexa TherapeuticsAlexey MargolinAlexey MargolinBoard Member · SynspiraJoe Cook JrJoe Cook JrFounder · Device Innovation GroupDan LynchDan LynchBoard Member · 2seventy bioJack NielsenJack NielsenBoard Member · ALX Oncology Holdings